PurMinds is an innovative precision NeuroMedicine company pursuing breakthrough solutions to neurodegenerative diseases, such as ALS, by progressing a robust clinical pipeline derived from multi-omics studies and an AI and data driven drug discovery platform.

PurMinds’ lead clinical and discovery pipeline includes small molecules, psychedelic and other candidates. Our PurPrecision™ NeuroMedicine Discovery Platform can generate unique molecular signatures of the diseases and novel therapeutic targets that directly inform and continuously refine and de-risk our pipeline.

We are looking for strategic investors who will share in the success of our growth, and also strategic partners for in-licensing, out-licensing, and AI/Machine Learning for potential partnership of promising drug targets.

PURMINDS Neuropharma Logo



Event details

Date: June 13 - 16, 2022

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


26 in total